OSEL Devices vs Q-Line Biotech
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
OSEL Devices currently has the stronger revenue growth signal.
OSEL Devices and Q-Line Biotech show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | OSEL Devices | Q-Line Biotech |
|---|---|---|
| Current Price | ₹346.45 | ₹600.55 |
| Market Cap | ₹616.5 Cr. | ₹1,400.97 Cr. |
| Industry | Healthcare Equipment & Supplies | — |
| P/E Ratio | 21.08 | 24.73 |
| ROE (%) | 19.56 | 25.97 |
| Debt/Equity | 0.49 | 0.92 |
| Sales Growth 5Y (%) | 38.54 | — |
| Profit Growth 5Y (%) | -36.91 | — |
| Promoter Holding (%) | 64.84 | 67.51 |
| Revenue Rank | Rank 1 | Rank 2 |
| Margin Rank | Rank 3 | Rank 1 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |